Skip to content
  • Sunday, 26 July 2026
  • 2:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • German Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia
Neuroscience & Brain Research

German Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic Ataxia

Rifan Muazin Jun 14, 2026 0

In a major advancement for the field of neurogenetics, a collaborative team of scientists in Germany has identified a previously…

Read More
Pharmaceutical R&D

Asahi Kasei acquires German company Aicuris

Teuku Ryan Apr 22, 2026 0

TOKYO, JAPAN – Asahi Kasei, a diversified Japanese chemical company with a significant and growing presence in healthcare, has officially…

Read More
Washington University Researchers Develop p-tau217 Blood Test Clock Capable of Predicting Alzheimer’s Symptom Onset Years in AdvanceRapid Evolution and Explosive Growth of Chronic Myeloid Leukemia Revealed by New Genomic StudyNew York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug componentEngineered Entanglement: How Staple-Shaped Particles are Redefining the Future of Reversible Materials and Sustainable Construction
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ